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Objectives The authors sought to compare the radiation dose between radial and femoral access.
Background Small trials have shown an increase in the radiation dose with radial compared with
femoral access, but many were performed during the operators’ learning curve of radial access.
Methods Patients were randomized to radial or femoral access, as a part of the RIVAL (RadIal Vs.
femorAL) trial (N  7,021). Fluoroscopy time was prospectively collected in 5740 patients and radia-
tion dose quantiﬁed as air kerma in 1,445 patients and dose-area product (DAP) in 2,255 patients.
Results Median ﬂuoroscopy time was higher with radial versus femoral access (9.3 vs. 8.0 min, p 
0.001). Median air kerma was nominally higher with radial versus femoral access (1,046 vs. 930 mGy,
respectively, p  0.051). Median DAP was not different between radial and femoral access (52.8 Gy-
cm2 vs. 51.2 Gy·cm2, p  0.83). When results are stratiﬁed according to procedural volume, air
erma was increased only in the lowest tertile of radial volume centers (low 1,425 vs. 1,045 mGy,
 0.002; middle 987 vs. 958 mGy, p  0.597; high 652 vs. 621 mGy, p  0.403, interaction p 
0.026). Multivariable regression showed procedural volume was the greatest independent predictor
of lower air kerma dose (ratio of geometric means 0.55; 95% conﬁdence interval 0.49 to 0.61 for
highest-volume radial centers).
Conclusions Radiation dose as measured by air kerma was nominally higher with radial versus femoral
access, but differences were present only in lower-volume centers and operators. High-volume centers
have the lowest radiation dose irrespective of which access site approach that they use. (A Trial of Trans-
radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients
With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy [RIVAL];
NCT01014273) (J Am Coll Cardiol Intv 2013;6:258–66) © 2013 by the American College of
Cardiology Foundation
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259Radiation exposure from cardiac procedures is an important
risk for both patients and physicians. Radiation has been
associated with an increased risk of cancer for patients under-
going cardiac procedures, based upon observational analyses
from administrative databases (1). Furthermore, radiation is
likely the most important occupational hazard for healthcare
providers working in cardiac catheterization laboratories. Small
randomized trials and observational studies have suggested that
the use of radial access leads to higher radiation doses for both
patients and healthcare workers compared with femoral access
(2–4). This increase in radiation may be due to the technical
challenges of using radial access, including subclavian tortuos-
ity and reduced guide support (5). However, a significant
limitation of some of the prior single-center studies is that
many may have been performed during the operators’ learning
curve of radial access.
The RIVAL (RadIal Vs. femorAL) trial was an interna-
tional multicenter randomized trial of 7,021 patients that
compared radial versus femoral access for coronary angiogra-
phy and intervention in patients with acute coronary syn-
dromes (ACS) (6). The overall trial showed no difference in
the primary outcome of death, myocardial infarction, stroke, or
non-coronary artery bypass surgery–related major bleeding
between groups; however, radial access was associated with a
more than 60% reduction in vascular access site complications
compared with femoral access. During the course of the trial,
detailed data relating to radiation exposure were collected.
The objective of this analysis was to compare the radia-
tion dose with radial versus femoral access as measured by
air kerma and dose-area product (DAP) and to determine
independent predictors of radiation dose.
Methods
Study design. The design of the RIVAL trial has been
published (7). It was a prospective randomized trial of
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M
apatients with ACS comparing radial versus femoral access
for coronary angiography and same-sitting percutaneous
coronary intervention (PCI) if clinically indicated. Between
June 6, 2006, and November 3, 2010, 7,021 patients were
enrolled from 158 hospitals in 32 countries (6).
Patients were eligible for RIVAL if: 1) they presented
with non–ST-segment elevation ACS or ST-segment ele-
vation ACS; 2) they were to be managed with an invasive
approach; 3) they had intact dual circulation of the hand
documented by Allen’s test; and 4) the interventional
cardiologist was willing to proceed with either the radial or
femoral approach (and had expertise for both, including at
least 50 radial procedures within the previous year).
Patients were not eligible for RIVAL if they presented
with cardiogenic shock, severe peripheral vascular disease
precluding a femoral approach, or prior coronary bypass
surgery using both internal mammary arteries.
Radiation measurements. Radiation measurements in the
orm of air kerma and DAP were collected in 2,569 patients
nrolled in the trial from sites that had the facilities to
rovide these measurements.
luoroscopy time was also col-
ected for both diagnostic and
CI procedures in the overall
opulation.
Air kerma is defined as the
adiation energy adsorbed per
nit mass of air (kg) and was
eported in milliGrays (mGy).
AP is a product of the air
erma and exposed area, and was
eported in Gy·cm2.
Statistical considerations. Base-
line characteristics were re-
corded for patients who had radiation measurements re-
ported (air kerma and/or DAP). Median air kerma, DAP,
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260and fluoroscopy times for radial versus femoral access were
compared using a Wilcoxon rank sum test because the data
were not normally distributed. All analyses were performed
as intention-to-treat. A significance level of 0.05 with a
2-sided test was used, and SAS version 9.1 (SAS institute,
Cary, North Carolina) was used for analyses.
Subgroups. We performed subgroup analysis identical to
those performed in the main RIVAL study, including
tertiles of radial PCI volume by center, tertiles of
individual radial operator volume, PCI versus no PCI,
age 75 years versus 75 years, sex, ST-segment eleva-
tion myocardial infarction (STEMI) versus non–ST-
segment elevation ACS, and body mass index (BMI)
25, 25 to 35, or 35 kg/m2. The tertiles of radial PCI
volume by center (expressed as median operator volume
at each center) were: 1) low (60 radial PCIs per year per
operator); 2) intermediate (61 to 146 radial PCIs per year
per operator); and 3) high (146 radial PCIs per year per
operator) (6). The tertiles of individual operator volume
were: 1) low (70 radial PCIs per year per operator); 2)
intermediate (71 to 142 radial PCIs per year per opera-
tor); and 3) high (142 radial PCIs per year per
operator) (6). Because fluoroscopy time, air kerma, and
DAP were not normally distributed, we performed logis-
tic regression for above and below the median to derive
an interaction p value for subgroups.
The measured air kerma was logarithmically transformed
because the distribution was positively skewed. To deter-
Table 1. Baseline Characteristics, Invasive Procedur
Radial (n 
Demographics
Mean age, yrs 63 1
Age 75 yrs 222 (17.
Men 914 (70.
Mean body mass index, kg/m2 28.0 4
Admission diagnosis
NSTEACS 919 (71.
STEMI 371 (28.
Prior history
Diabetes mellitus 290 (22.
Myocardial infarction 212 (16.
Percutaneous coronary intervention 156 (12.
Coronary artery bypass graft surgery 31 (2.4
Peripheral vascular disease 37 (2.9
Interventions during initial hospitalization
Percutaneous coronary intervention 798 (61.
Stent* 753 (94.
Coronary artery bypass grafting 138 (10.
Values are mean SD or n (%). *As a proportion of patients having peNSTEACS non–ST-segment elevation acute coronary syndromes; STEMImine independent predictors of air kerma, multivariable
linear regression was performed utilizing known predictors
of radiation dose, which include age, sex, radial access,
diabetes, prior coronary artery bypass grafting, BMI, prior
peripheral arterial disease, PCI, 100% occlusion of culprit
lesion, STEMI, and tertiles of center radial PCI volume and
then repeated using tertiles of operator radial PCI volume.
Ratios of the geometric means were back transformed to
provide a clinically relevant estimate of the predictive value
of each of the preceding variables. The same approach was
followed for DAP, which also had a positively skewed
distribution.
Results
Of the 7,021 patients enrolled in the RIVAL trial, 2,569
patients at 42 centers in 16 countries had a radiation
measurement reported in the form of air kerma or DAP for
their index procedure. Of these 2,569 patients, 1,445 had air
kerma reported and 2,255 had DAP reported, whereas
1,131 had both air kerma and DAP reported.
Baseline characteristics for the patients with radiation
measurements, shown in Table 1, are well balanced between
radial and femoral access and similar to the overall trial
participants.
Overall radial versus femoral access. Fluoroscopy time was
ncreased with radial compared with femoral access (radial
.3 min vs. femoral 8.0 min, p 0.0001) (Table 2). Median
Radiation Substudy Patients
tion Substudy
Overall RIVAL Population
(N  7,021)) Femoral (n  1,279)
63 12 62 12
235 (18.4) 1,035 (14.7)
931 (72.8) 5,160 (73.5)
28.0 4.8 27.6 4.7
903 (70.6) 5,063 (72.1)
376 (29.4) 1,958 (27.9)
260 (20.3) 1,503 (21.4)
199 (15.6) 1,280 (18.2)
151 (11.8) 839 (11.9)
32 (2.5) 154 (2.2)
29 (2.3) 173 (2.5)
809 (63.3) 4,660 (66.4)
770 (95.2) 4,420 (94.8)
135 (10.6) 599 (8.5)
eous coronary intervention.es for
Radia
1,290
2
2)
9)
.7
2)
8)
5)
4)
1)
)
)
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261air kerma was increased nominally with radial compared
with femoral access (1,046 vs. 930 mGy, respectively, p 
0.051) (Table 3). Median DAP was not different between
radial and femoral access (52.8 vs. 51.2 Gy·cm2, p  0.83)
Table 4).
Procedural volume and radial versus femoral access. When
enters were stratified into tertiles of radial PCI volume,
uoroscopy time was increased with radial compared with
emoral access in low-volume (10 vs. 8.5 min, p  0.001)
nd middle-volume centers (9.5 vs. 7.8 min, p  0.001). At
he individual operator level, fluoroscopy time was increased
n all 3 tertiles of operator volume. There were significant
nteractions with much smaller differences of fluoroscopy
ime in high-volume centers (8.3 vs. 8.0 min, p  0.059,
nteraction p  0.021) and among high-volume operators
8.7 vs. 8.0 min, p  0.024, interaction p  0.002)
Table 2).
Air kerma was increased with radial versus femoral access
nly in the lowest-volume radial centers (low 1,425 vs.
,045 mGy, p  0.002; middle 987 vs. 958 mGy, p 
.597; high 652 vs. 621 mGy, p  0.403; interaction p 
Table 2. Median Fluoroscopy Times With Radial Vers
Radial (Min)
Overall (N  5,740) 9.3 (5.8–15.0)
Radial center volume
Low (n  1,551) 10.0 (6.7–16.0)
Middle (n  2,331) 9.5 (5.1–15.0)
High (n  1,858) 8.3 (5.0–13.4)
Radial operator volume
Low (n  1,814) 10.9 (6.7–16.4)
Middle (n  1,946) 9.0 (5.0–14.1)
High (n  1,975) 8.7 (5.3–14.0)
PCI vs. no PCI
PCI (n  4,544) 11.0 (7.2–16.7)
No PCI (n  1,196) 3.9 (2.3–6.4)
Diagnosis at presentation
STEMI (n  1,803) 9.3 (6.0–15.0)
NSTEACS (n  3,937) 9.3 (5.1–15.0)
Age, yrs
75 (n  4,881) 9.2 (5.9–14.6)
75 (n  859) 9.8 (5.3–16.0)
Sex
Female (n  1,485) 8.0 (4.2–14.0)
Male (n  4,255) 9.9 (6.0–15.0)
BMI, kg/m2
25 (n  1,676) 9.0 (5.0–14.0)
25–35 (n  3,665) 9.7 (6.0–15.0)
35 (n  382) 10.8 (5.3–16.0)
Values are median (interquartile range). *Interaction above and below
BMI body mass index; PCI percutaneous coronary intervention.026) (Fig. 1, Table 3). When results were stratified by Fertiles of operator radial PCI volume, air kerma was only
ncreased in low-volume radial operators with radial com-
ared with femoral access (Fig. 2, Table 3), but the
nteraction term was not significant (p  0.263).
When centers were stratified into tertiles of radial PCI
olume, DAP was not different between radial and femoral
n all 3 tertiles (Table 4). When results were stratified by
ertile of individual operator volume, DAP was increased in
ow-volume radial operators with radial access (low 60
y·cm2 vs. 50 Gy·cm2, p 0.046; middle 55 Gy·cm2 vs. 55
Gy·cm2, p  0.643; high 42 Gy·cm2 vs. 44 Gy·cm2,
 0.605), but the interaction term was not significant
p  0.072) (Table 4).
Other subgroups. For fluoroscopy time, there were consis-
tent findings of increased fluoroscopy time for radial versus
femoral access in all subgroups as shown in Table 2. Air
kerma levels were significantly higher with radial com-
pared with femoral access in only those patients with
STEMI (1,272 vs. 1,072 mGy, p  0.039, interaction
p  0.763) and those who underwent PCI (1,317 vs.
,230 mGy, p  0.040, interaction p  0.085) (Table 3).
moral Access
moral (Min) p Value
Interaction
p Value*
.0 (4.5–13.0) 0.001
.5 (5.0–13.0) 0.001 0.021
.8 (4.0–13.0) 0.001
.0 (5.0–13.0) 0.059
.2 (5.0–13.0) 0.001 0.002
.3 (4.0–12.8) 0.001
.0 (5.0–13.1) 0.024
.5 (6.0–15.0) 0.001 0.180
.5 (1.6–4.1) 0.001
.0 (5.0–13.0) 0.001 0.274
.0 (4.0–13.0) 0.001
.0 (4.5–13.0) 0.001 0.906
.0 (4.1–13.2) 0.001
.0 (4.0–12.1) 0.002 0.146
.0 (5.0–13.1) 0.001
.0 (4.1–13.0) 0.006 0.260
.0 (4.5–13.0) 0.001
.0 (5.0–13.0) 0.008
n.
bbreviations as in Table 1.us Fe
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262between radial and femoral access in the additional
subgroups (Table 4).
Independent predictors of air kerma were radial center
volume, PCI for index procedure, 100% occlusion of culprit
lesion, radial access group, female, BMI, and diabetes (Fig. 3). On
the basis of the ratios of the geometric means, the 2 most
important predictors were PCI (ratio 2.29; 95% confidence
interval [CI]: 2.13 to 2.47) and high radial center volume
(ratio 0.55; 95% CI: 0.49 to 0.61) (Fig. 3). When the
analysis was repeated utilizing radial operator instead of
center volume, the overall results were similar, and radial
operator volume was a significant predictor of air kerma
(ratio 0.74; 95% CI: 0.68 to 0.82) (Online Fig. 1).
Independent predictors of DAP were radial center vol-
ume, PCI for index procedure, 100% occlusion of culprit
lesion, female, diabetes, prior CABG, BMI, and peripheral
vascular disease (Fig. 4). Radial access was not a significant
independent predictor of DAP (ratio 1.04; 95% CI: 0.97 to
1.11). When the analysis was repeated using radial operator
instead of center volume, the overall results were similar, and
radial operator volume was a significant independent predictor
Table 3. Median Air Kerma With Radial Versus Femo
Radial (mGy)
Overall (N  1,445) 1,046 (584–1,591)
Radial center volume
Low (n  320) 1,425 (859–1,934)
Middle (n  867) 987 (621–1,477)
High (n  258) 652 (305–1,255)
Radial operator volume
Low (n  348) 1,152 (751–1,754)
Middle (n  695) 1,065 (611–1,525)
High (n  402) 847 (408–1,564)
PCI vs. no PCI
PCI (n  946) 1,317 (951–1,902)
No PCI (n  499) 556 (325–839)
Diagnosis at presentation
STEMI (n  462) 1,272 (699–1,973)
NSTEACS (n  983) 950 (537–1,450)
Age, yrs
75 (n  1,193) 1,084 (612–1,660)
75 (n  252) 785 (475–1,371)
Sex
Female (n  399) 683 (343–1,185)
Male (n  1,046) 1,161 (672–1,729)
BMI, kg/m2
25 (n  395) 729 (409–1,287)
25–35 (n  923) 1,084 (647–1,603)
35 (n  124) 1,355 (782–2,160)
Values are median (interquartile range). *Interaction above and below
Abbreviations as in Tables 1 and 2.of DAP (ratio 0.82; 95% CI: 0.74 to 0.90) (Online Fig. 2).Discussion
The RIVAL trial is the first large, international multi-
center randomized trial to compare the radiation dose of
radial versus femoral access for coronary interventions.
Although fluoroscopy time was increased with radial
compared with femoral access, radiation dose as mea-
sured by air kerma was only nominally increased with
radial access, with this difference only occurring in
low-volume radial centers. By contrast, radiation dose as
measured by DAP was not different between radial and
femoral access. Finally, procedural volume appears to be
a more important predictor of radiation dose than either
radial or femoral access, thereby underscoring the impor-
tance of operator and center experience regardless of
access site used.
In the overall RIVAL trial, a significant interaction for
the primary outcome was observed for radial center
volume with a benefit observed for radial access in the
highest tertile of center volume. The results of the
present analysis reinforce the concept that expertise and
cess
emoral (mGy) p Value
Interaction
p Value*
930 (538–1,572) 0.051
045 (636–1,674) 0.002 0.026
958 (571–1,616) 0.597
621 (226–1,263) 0.403
945 (583–1,564) 0.007 0.263
990 (583–1,667) 0.680
728 (365–1,482) 0.304
230 (814–1,837) 0.040 0.085
534 (335–767) 0.433
072 (618–1,711) 0.039 0.763
863 (500–1,502) 0.267
980 (564–1,629) 0.082 0.952
735 (449–1,320) 0.508
641 (346–1,112) 0.831 0.961
037 (621–1,717) 0.056
667 (402–1,193) 0.445 0.321
020 (604–1,575) 0.174
275 (732–2,306) 0.966
n.ral Ac
F
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mediatraining are important for radial access. It was previously
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263unknown whether the observed increase in radiation dose
related to radial compared with femoral access could be
overcome with increased training. It is clear from this
analysis from the RIVAL trial that high-volume centers
and operators are able to achieve similar radiation doses
as measured by air kerma with either access site approach.
Table 4. Median DAP With Radial Versus Femoral Ac
Radial (Gy·cm2) F
Overall (N  2,255) 53 (26–87)
Radial center volume
Low (n  467) 61 (30–99)
Middle (n  1,323) 55 (28–85)
High (n  465) 43 (19–80)
Radial operator volume
Low (n  617) 60 (31–95)
Middle (n  1,128) 55 (28–86)
High (n  510) 42 (20–74)
PCI vs. no PCI
PCI (n  1,392) 71 (40–110)
No PCI (n  863) 33 (19–56)
Diagnosis at presentation
STEMI (n  636) 66 (37–103)
NSTEACS (n  1,619) 47 (24–80)
Age, yrs
75 (n  1,836) 54 (26–91)
75 (n  419) 46 (28–76)
Sex
Female (n  652) 37 (20–67)
Male (n  1,603) 60 (34–97)
BMI, kg/m2
25 (n  607) 37 (18–67)
25–35 (n  1,461) 57 (31–93)
35 (n  183) 70 (33–120)
Values are median (interquartile range). *Interaction above and below
Abbreviations as in Tables 1 and 2.
1600
P=0.002
1425
1200
1400
Interacon P=0.026
P=0.597
987
1045
958
800
1000
Radial
P=0.403
652 621
400
600
Femoral
0
200
Low Middle HighFigure 1. Air Kerma (mGy) by Radial Center VolumeThe magnitude of differences observed between low- and
high-volume centers was much greater than that between
access site approaches. This suggests that operator training
and education are very important to reduce the radiation
exposure to patients, operators, and healthcare workers
working in cardiac catheterization laboratories.
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264Why a difference in ﬂuoroscopy time and not other measures,
such as DAP? Most of the radiation for PCI is from
cine-angiography with only a small minority from fluoros-
copy. As a result, fluoroscopy time is a poor surrogate
measure of radiation dose for the patient. Small increases in
fluoroscopy time during crossing of the subclavian artery or
traversing the brachial artery with radial access do not
appear to lead to significant increases in total radiation dose
compared with femoral access.
Clinicians may ask why a difference was observed for
fluoroscopy time and a trend for air kerma but not DAP. A
potential reason is that DAP is dependent on the size of the
radiation field so that imaging practices such as differential
coning by operators could have led to similar DAP between
the groups despite nominal differences in air kerma. By
contrast, differential coning would not have affected air
kerma values.
Previous observational analyses have suggested that radial
access may be associated with an increased radiation dose,
but this may have been confounded by selection bias (8).
The 3 prior randomized trials of radial versus femoral access
examining radiation dose were limited by the fact that they
were: 1) single-center trials with a small number of opera-
Air kerma
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Figure 3. Ratios of Geometric Means From Multivariable Logistic Regressi
BMI  body mass index; CABG  coronary artery bypass grafting; CI  conﬁd
vention; STEMI  ST-segment elevation myocardial infarction.tors; 2) did not report air kerma values; and 3) did not reportoutcomes by procedural volume (2–4). In these trials, 2
demonstrated increased DAP and fluoroscopy time with
radial compared with femoral access, and 1 trial showed no
difference.
From a patient perspective, the small overall differences in
air kerma (approximately 100 mGy or 10% increase) be-
tween radial and femoral access for a single procedure is
likely to have minimal risk for subsequent cancer based on
the available literature. The impact for the operator over a
30-year career is likely to be more significant, with a 10%
increase representing an additional 3 years of radiation
equivalent. However, this increase associated with radial
access can likely be avoided with increased training and
procedural volume.
Measures to reduce operator radiation dose should be
used irrespective of the access site and include transpar-
ent, ceiling-mounted shielding, below-table shielding,
and use of stored fluoroscopy when possible (9). Dispos-
able radiation blocking drapes and lead shields draped
over the patient may further lower operator radiation
dose (10,11).
Study limitations. Personalized dosimeter measurements for
healthcare workers performing the procedures were not
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265radiation doses received by the patients. The type of x-ray
system was not collected as part of the study. As a result, it
is possible that centers with more modern systems partici-
pated in the radiation substudy because these systems
routinely report air kerma and DAP. As a result, these
results may be more applicable to centers with modern x-ray
systems. Finally, the participation of trainees was not
recorded on case report forms, and participation of trainees
can increase radiation dose. Despite these limitations, this is
the largest randomized trial to assess the radiation dose
between radial and femoral access and the effect of proce-
dural volume.
Conclusions
Radiation dose as measured by air kerma is nominally
higher with radial versus femoral access, but differences are
present only in lower-volume centers and operators. Proce-
dural volume was a more important predictor of radiation
dose than choice of access site. Experience is the most
important factor in reducing radiation exposure from coro-
nary procedures regardless of whether radial or femoral
DAP
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